Dyadic International Faces Delisting Concerns
Ticker: DYAI · Form: 8-K · Filed: Dec 29, 2025 · CIK: 1213809
| Field | Detail |
|---|---|
| Company | Dyadic International Inc (DYAI) |
| Form Type | 8-K |
| Filed Date | Dec 29, 2025 |
| Risk Level | high |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $1 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Dyadic International might get delisted - stock exchange rules are a problem.
AI Summary
Dyadic International, Inc. filed an 8-K on December 29, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event reported on December 19, 2025. The company, incorporated in Delaware, is involved in Biological Products.
Why It Matters
This filing indicates potential issues with Dyadic International's compliance with stock exchange listing requirements, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued trading on an exchange.
Key Players & Entities
- Dyadic International, Inc. (company) — Registrant
- December 19, 2025 (date) — Earliest event reported
- December 29, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Biological Products (industry) — Standard Industrial Classification
FAQ
What specific listing rule or standard has Dyadic International, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Dyadic International, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the earliest date of the event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on December 19, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed with the SEC on December 29, 2025.
What is Dyadic International, Inc.'s Standard Industrial Classification code and description?
Dyadic International, Inc.'s Standard Industrial Classification is 2836, described as Biological Products (no diagnostic substances).
What is the principal executive office address for Dyadic International, Inc.?
The principal executive office address for Dyadic International, Inc. is 1044 North U.S. Highway One, Suite 201, Jupiter, FL 33477.
Filing Stats: 1,107 words · 4 min read · ~4 pages · Grade level 16.5 · Accepted 2025-12-23 20:30:26
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share DYAI The Nasdaq Stock Mar
- $1 — ained the minimum bid price of at least $1 per share required by the continued lis
Filing Documents
- form8-k.htm (8-K) — 44KB
- form8-k_001.jpg (GRAPHIC) — 5KB
- 0001493152-25-029141.txt ( ) — 221KB
- dyai-20251219.xsd (EX-101.SCH) — 3KB
- dyai-20251219_lab.xml (EX-101.LAB) — 33KB
- dyai-20251219_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. (a) On December 19, 2025, Dyadic International, Inc. (the "Company") received a deficiency notice (the "Notice") from the Nasdaq Listing Qualifications staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that for the last 30 consecutive business days the Company's securities have not maintained the minimum bid price of at least $1 per share required by the continued listing requirements of Nasdaq Listing Rule 5550(a)(2). The Notice has no immediate effect on the listing of the Company's common stock on the Nasdaq Capital Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days, or until June 17, 2026 (the "Compliance Date"), to regain compliance with the minimum bid price requirement by having the Company's bid price close at $1 per share or more for a minimum of 10 consecutive business days before the Compliance Date (subject to the Staff's discretion to extend this period under Nasdaq Listing Rule 5810(c)(3)(H)). If the Company does not regain compliance by the Compliance Date, the Company may be eligible for an additional 180-day period to regain compliance, provided that on the Compliance Date the Company meets the applicable market value of publicly held shares requirement for continued listing and all other applicable standards for initial listing on the Nasdaq Capital Market (except the bid price requirement) based on the Company's most recent public filings and market information and provides Nasdaq with written notice of its intent to cure this deficiency. However, if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible for the second compliance period, and the Company does not regain compliance by the Compliance Date, the Staff will provide written notification that the Company's common stock is subjec
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 23, 2025 Dyadic International, Inc. By: /s/ Ping Rawson Name: Ping Rawson Title: Chief Financial Officer